InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,745.37
(
0.40%
)
US TECH 100
19,572.00
(
0.72%
)
Dow Jones
42,175.11
(
0.62%
)
Brent Oil
70.88
(
-0.11%
)
Bitcoin
64,890.70
(
-0.45%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

MightyLion

Send PM Follow Ignore
Followers 0
Posts 224
Boards Moderated 0
Alias Born 04/21/2014

MightyLion

Re: Trader Joey post# 66073

Sunday, 05/11/2014 8:28:35 PM

Sunday, May 11, 2014 8:28:35 PM

Post# of 92948
They do have revenue, it's just not exactly significant.. however this is an R&D stage company, and significant revenues are not expected at this stage - investment at this level is based on risk/reward tolerance of future returns, not current. If you want to invest based on current revenues, go buy blue chip and collect dividends, because the OTC market is not the place for that.

BTW, this is directed at the individual you were responding to TJ, and anyone who is also unfamiliar with ACTC, R&D biotechs, and the OTC market in general.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up